John Frater

17PUBLICATIONS
142CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityEpidemiological methodsDeep learningPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 12, 2026
T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

Mohammed Altaf, Carla Nel, Timothy Tipoe

|Nov 24, 2025
Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.

Marcilio J Fumagalli, Anna Kaczynska, Marius Allombert

|Jan 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.

Jesper D Gunst, Jesal Gohil, Johanthan Z Li

|Nov 20, 2024
Learning patterns of HIV-1 resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning.

Aime Bienfait Igiraneza, Panagiota Zacharopoulou, Robert Hinch

|Oct 28, 2024
Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection.

Weiwei Sun, Ce Gao, Gregory Takashi Gladkov

|Apr 20, 2024
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery.

Mohammad Ali, Stephanie Longet, Isabel Neale

Pageof 3

Frequent Collaborators

5 joint publications

Eleanor Barnes

4 joint publications

Christopher P Conlon

4 joint publications

Susanna J Dunachie

4 joint publications

Donal T Skelly